| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8740603 | Journal of Infection and Chemotherapy | 2018 | 6 Pages |
Abstract
In Japan, PAM may be selected as a first-line treatment for young people with H. pylori if antibiotic susceptibility tests cannot be performed.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Katushiro Mabe, Masumi Okuda, Shogo Kikuchi, Kenji Amagai, Rie Yoshimura, Mototsugu Kato, Naoya Sakamoto, Masahiro Asaka, Japan Gast Study Group Japan Gast Study Group,